Abstract:Although microglial polarization and neuroinflammation are crucial cellular responses after traumatic brain injury, the fundamental regulatory and functional mechanisms remain insufficiently understood. As potent anti-inflammatory agents, the use of glucocorticoids in traumatic brain injury is still controversial, and their regulatory effects on microglial polarization are not yet known. In the present study, we sought to determine whether exacerbation of traumatic brain injury caused by high-dose dexamethasone is related to its regulatory effects on microglial polarization and its mechanisms of action. In vitro cultured BV2 cells and primary microglia and a controlled cortical impact mouse model were used to investigate the effects of dexamethasone on microglial polarization. Lipopolysaccharide, dexamethasone, RU486 (a glucocorticoid receptor antagonist), and ruxolitinib (a Janus kinase 1 antagonist) were administered. RNA-sequencing data obtained from a C57BL/6 mouse model of traumatic brain injury were used to identify potential targets of dexamethasone. The Morris water maze, quantitative reverse transcription-polymerase chain reaction, western blotting, immunofluorescence and confocal microscopy analysis, and TUNEL, Nissl, and Golgi staining were performed to investigate our hypothesis. High-throughput sequencing results showed that arginase 1, a marker of M2 microglia, was significantly downregulated in the dexamethasone group compared with the traumatic brain injury group at 3 days post-traumatic brain injury. Thus dexamethasone inhibited M1 and M2 microglia, with a more pronounced inhibitory effect on M2 microglia in vitro and in vivo. Glucocorticoid receptor plays an indispensable role in microglial polarization after dexamethasone treatment following traumatic brain injury. Additionally, glucocorticoid receptor activation increased the number of apoptotic cells and neuronal death, and also decreased the density of dendritic spines. A possible downstream receptor signaling mechanism is the GR/JAK1/STAT3 pathway. Overactivation of glucocorticoid receptor by high-dose dexamethasone reduced the expression of M2 microglia, which plays an anti-inflammatory role. In contrast, inhibiting the activation of glucocorticoid receptor reduced the number of apoptotic glia and neurons and decreased the loss of dendritic spines after traumatic brain injury. Dexamethasone may exert its neurotoxic effects by inhibiting M2 microglia through the GR/JAK1/STAT3 signaling pathway.

Noradrenergic Activity Regulated Dexamethasone-Induced Increase of 5-Ht3 Receptor-Mediated Glutamate Release in the Rat'S Prelimbic Cortex

Glucocorticoid Exerts Its Non-Genomic Effect on Ipsc by Activation of A Phospholipase C-Dependent Pathway in Prefrontal Cortex of Rats

Neuroactive steroid dehydroepiandrosterone sulfate inhibits 5-hydroxytryptamine (5-HT)-evoked glutamate release via activation of σ-1 receptors and then inhibition of 5-HT3 receptors in rat prelimbic cortex

Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor.

Inhibition of Nerve Growth Factor-Induced Neurite Outgrowth from PC12 Cells by Dexamethasone: Signaling Pathways through the Glucocorticoid Receptor and Phosphorylated Akt and ERK1/2

Rapid Enhancement of High Affinity Glutamate Uptake by Glucocorticoids in Rats Cerebral Cortex Synaptosomes

A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system

Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone

Dexmedetomidine Improves the Acute Stress Reactivity of Male Rat Through Interventions of Serum- and Glucocorticoid-Inducible Kinase 1 and Nnos in the Bed Nucleus of the Stria Terminalis.

Effects of dexmedetomidine on depression-like behaviour in chronic restraint stress mice: Involvement of specific brain regions

Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients.

Noradrenaline activation of hippocampal dopamine D1 receptors promotes antidepressant effects

β3-adrenoceptor activation exhibits a dual effect on behaviors and glutamate receptor function in the prefrontal cortex

Role of the NMDA receptor in cognitive deficits, anxiety and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure

High-dose dexamethasone regulates microglial polarization via the GR/JAK1/STAT3 signaling pathway after traumatic brain injury

Neurosteroid Enhances Glutamate Release in Rat Prelimbic Cortex Via Activation of Α 1 -Adrenergic and Σ 1 Receptors

Integrated Profiling Identifies Long-Term Molecular Consequences of Prenatal Dexamethasone Treatment in the Rat Brain—Potential Triggers of Depressive Phenotype and Cognitive Impairment

Fluvoxamine Increased Glutamate Release by Activating Both 5-HT(3) and Sigma-1 Receptors in Prelimbic Cortex of Chronic Restraint Stress C57BL/6 Mice.

Combined Β-Adrenergic and Corticosteroid Receptor Activation Regulates AMPA Receptor Function in Hippocampal Neurons

Dexmedetomidine inhibits paraventricular corticotropin-releasing hormone neurons that attenuate acute stress-induced anxiety-like behavior in mice

Dexamethasone Changes the Pharmacokinetics of Amitriptyline and Reduces Its Accumulation in Rat Brain: the Roles of P-gp and Cyp3a2.